Distinct requirements for Ras oncogenesis in human versus mouse cells.
about
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growthHuman CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathwaysThe tumor suppressor PP2A Abeta regulates the RalA GTPaseDistinct roles of RalA and RalB in the progression of cytokinesis are supported by distinct RalGEFs.Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPasesElevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activityEvolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotypeGenetic alterations in pancreatic carcinomaEngineered Swine Models of CancerThe Exocyst at a GlanceThe Structure of the RLIP76 RhoGAP-Ral Binding Domain Dyad: Fixed Position of the Domains Leads to Dual Engagement of Small G Proteins at the MembraneReceptor tyrosine kinases exert dominant control over PI3K signaling in human KRAS mutant colorectal cancers.Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeRLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosisCopper is required for oncogenic BRAF signalling and tumorigenesisRal GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformationIdentification and characterization of rain, a novel Ras-interacting protein with a unique subcellular localizationRal GTPases: crucial mediators of exocytosis and tumourigenesisRal GTPases in tumorigenesis: emerging from the shadowsOncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Ral-dependent and Ral-independent mechanismsOncogenic RAS directs silencing of tumor suppressor genes through ordered recruitment of transcriptional repressorsBRAF mutation predicts sensitivity to MEK inhibitionRas oncogenes: split personalitiesRal-Arf6 crosstalk regulates Ral dependent exocyst trafficking and anchorage independent growth signallingErk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth.Ras history: The saga continues.Transcriptional signatures of Ral GTPase are associated with aggressive clinicopathologic characteristics in human cancer.The Ral/exocyst effector complex counters c-Jun N-terminal kinase-dependent apoptosis in Drosophila melanogaster.R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes.Ras effector switching promotes divergent cell fates in C. elegans vulval patterning.RALA and RALBP1 regulate mitochondrial fission at mitosisRalA activation at nascent lamellipodia of epidermal growth factor-stimulated Cos7 cells and migrating Madin-Darby canine kidney cells.Targeting pathways downstream of KRAS in lung adenocarcinoma.RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1Ral is both necessary and sufficient for the inhibition of myeloid differentiation mediated by RasCombined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.Distinct functions of POT1 at telomeres.TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
P2860
Q24294230-9A011915-8046-4152-A9BA-8F6F8DDE1ED4Q24306587-04EE8A10-6F9E-4224-B51D-1ACE5E3776D5Q24307546-8A95E4BA-025F-4E8E-9A0C-5E522B4ADFF4Q24337038-C5D86014-D7AA-4DE5-BF9A-44E9B87D8D16Q24337797-07276322-89DA-4FEC-9566-DF9226190465Q24554279-B38AD7A2-E2A2-4653-B1D3-FC147F5CCBA8Q24557505-BBBDD5DC-ACB0-4969-9A9B-53A9CBA22663Q24801345-B25C58C4-724D-4B38-886F-3806FF3E427AQ24801465-E297994A-ECD9-49DE-91BF-0893E0D2011EQ26744575-1D8DA83F-EE13-45D3-B99C-4AE8B7B5B7FBQ26799386-F87A8246-A462-440D-8D48-E3DD1EE68FBAQ27680559-4680C985-7F44-4649-8B20-2150135232F5Q27851674-6A2A5C62-CE8C-449B-8A50-7810EBAFA8EBQ27851703-63E3D4CC-E17E-42C7-95F9-E3B0AF0F9A40Q28207629-23975D70-AC4B-40F2-B7DA-A34303931E1EQ28237892-9B9341B0-5DC5-4ECF-B574-B2BF1B7ED81FQ28247699-C642AEA5-D476-49B9-B2B2-EBE3302EA36BQ28251364-91E32A68-780A-4841-A2AE-ADA861E91415Q28259292-907F5955-7679-40C7-96D4-72FBE15F917CQ28294053-3E14E115-00CC-47D6-ACDB-E5618EB9E676Q28301952-56DE7A95-FC2F-4042-A045-260E9E13F0C7Q28384212-FA77ABB1-C050-42ED-BC3F-B1160E997147Q28510632-35F0EE95-3539-47BD-9E2D-2D5939FA8707Q29614281-1A5622BE-0A06-4EE0-A210-88EE9B06A8A2Q29615405-C04C7B75-AF91-497C-8961-312794CF3DADQ30276654-3D241CB4-E0DC-4967-880B-C6724B55D728Q30300846-EE91425B-F8E7-472C-8058-1DAAFD0B2B1BQ30404024-B81B032B-74C3-4543-A761-AAD5AD100F4CQ30416201-D2085C9D-3442-4C25-96BD-D29A67CFAD34Q30478286-8695F32F-D58B-410F-BA73-E1851E3EAB76Q30479311-0EA00708-5756-495E-97F8-94A2D9FF2870Q30498007-F0930C3F-B56D-4CA0-839D-3072B6684526Q30503960-2C7F6F49-6667-4D00-A930-1303C8721528Q30593702-DEE1CEA1-B202-44DC-ADF7-05E2A26200B2Q30597330-7847015A-B48C-4EEF-A31A-D7BE9BCB32A8Q30657060-F7269270-488D-4EBB-A42D-682F11C8ED74Q33241589-0A6019F5-9955-4C81-8AE9-F215ED65E7D4Q33332189-5DBF712B-8D7D-45F4-89F2-15059A1F582FQ33339823-ED0BC649-6A99-482C-910B-68709C6948EAQ33348778-1397EA61-DC3E-4B20-910E-FA6B1290E30D
P2860
Distinct requirements for Ras oncogenesis in human versus mouse cells.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@ast
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@en
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@nl
type
label
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@ast
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@en
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@nl
prefLabel
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@ast
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@en
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@nl
P2093
P2860
P356
P1433
P1476
Distinct requirements for Ras oncogenesis in human versus mouse cells.
@en
P2093
Antoine E Karnoub
Channing J Der
Christopher M Counter
Jeremy N Rich
Joel H Elconin
Nesrin M Hamad
Robert T Abraham
P2860
P304
P356
10.1101/GAD.993902
P577
2002-08-01T00:00:00Z